Dexamethasone transdermal (Teikoku Pharma USA)

N/A

Report date: 2025/11/14 14:12:18

Base Information

Drug NameDexamethasone transdermal (Teikoku Pharma USA)
Drug Alias NameTPW-182
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBangladesh
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTeikoku Pharma Usa Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXi'An Jiaotong University Health Science Center
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A